2022 annual financial data
Nuvectis Pharma 2022 Net margin
Direct answer
Net margin was -12,608.72%.
Operating income was -19,234,000 USD and net income was -18,787,000 USD.
Operating cash flow was -13,559,000 USD.
Get free Nuvectis Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 149,000 USD
- Operating income
- -19,234,000 USD
- Net income
- -18,787,000 USD
- Operating cash flow
- -13,559,000 USD